Health ❯Healthcare ❯Diabetes ❯Diabetes Management
The regulator said the drugs are unsuitable in pregnancy or breastfeeding because of fetal safety concerns, noting that Mounjaro can reduce oral contraceptive effectiveness in overweight women.
